Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Organigram
Pharmaceutical Preparation ManufacturingCanadaBSE: EPIGRAL.BO
Last verified 27 days agoorganigram.ca
Organigram Holdings Inc., commonly referred to as Organigram, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Moncton, New Brunswick, Canada. Founded in 2013, the company has rapidly established itself as a key provider of high-quality cannabis products, focusing on both medical and recreational markets across Canada.
With a commitment to innovation, Organigram offers a diverse range of products, including dried flower, oils, and edibles, all crafted with precision and care. The company is renowned for its unique approach to cultivation and processing, utilising advanced technology to ensure consistency and quality.
As a publicly traded entity, Organigram has achieved significant milestones, including strategic partnerships and expansions that solidify its market position. With a strong emphasis on research and development, Organigram continues to lead the way in the evolving cannabis landscape, setting standards for excellence in the industry.
26
DitchCarbon score
-16 vs industry average
Organigram’s score of 26 is lower than 38% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Organigram?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2022
202020212022
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Organigram's reported carbon emissions
Organigram, a Canadian pharmaceutical preparation manufacturer, reported total carbon emissions of approximately 1,575,000 kg CO2e in 2022. This represents an increase from their 2021 emissions of approximately 1,229,000 kg CO2e. The disclosed emissions data for both years does not specify the breakdown by Scope 1, Scope 2, or Scope 3 emissions. Organigram has not publicly disclosed specific carbon reduction targets or commitments, nor are they a signatory to the Science Based Targets initiative (SBTi).
Assessing Organigram as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Organigram and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Organigram’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Organigram yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Organigram27 days ago
26
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more